10 Best Non-Mega Cap NASDAQ Stocks to Buy Right Now

3. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Average analyst upside: 27.5%

Market cap: $59.16 billion

Number of Hedge Fund Holders: 66

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Best Non-Mega Cap NASDAQ Stocks to Buy Right Now. UBS analyst Trung Huynh raised the price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $584 from $560 while maintaining a Neutral rating ahead of the company’s second-quarter earnings report.

The move reflects slightly more optimistic expectations for Regeneron’s financial performance, particularly driven by the continued strength of its flagship eye treatment, Eylea. The franchise has shown resilience amid increased competition in the ophthalmology space, and investor attention is likely to focus on how well Regeneron has defended its market share.

Despite the upward revision, UBS remains cautious on the stock, pointing to a balance of risks and rewards in the near term. While the company has a robust pipeline and strong positioning in its core therapeutic areas, the firm believes the current share price already reflects much of the near-term optimism.

The note also signals that while the broader biotech sector has experienced renewed investor interest, Regeneron’s valuation leaves limited room for upside unless new catalysts emerge. The stock has performed steadily in recent months, and the upcoming earnings release may serve as a key moment for reassessing momentum into the second half of the year.